论文检索
期刊
全部知识仓储预印本开放期刊机构
高级检索

特发性非肝硬化门静脉高压症的关键基因通路筛选与潜在中药预测OA

Screening of hub genes and pathways of idiopathic non-cirrhotic portal hypertension and prediction of traditional Chinese medicine

中文摘要英文摘要

目的 采用生物信息学方法对特发性非肝硬化门静脉高压症(idiopathic non-cirrhotic portal hypertension,INCPH)的基因芯片数据进行分析,获取疾病发生发展的关键基因和信号通路,预测治疗INCPH的潜在中药.方法 从基因表达综合数据库(gene expression omnibus,GEO)数据库下载关于INCPH的基因芯片数据集GSE77627,利用R语言对数据进行标准化并筛选INCPH的差异基因(differential genes,DEGs),并利用Metascape数据库对所有DEGs进行基因本体(gene ontology,GO)和京都基因与基因组百科全书(Kyoto encyclopedia of genes and genomes,KEGG)富集分析,并通过STRING数据库构建蛋白-蛋白互作网络;同时,利用CytoHubba插件筛选Degree值排名前 15 的DEGs作为关键基因.随后将关键基因与医学本体信息检索平台互相映射,以P<0.05 为标准筛选治疗INCPH的潜在中药,并从TCMSP数据库中筛选潜在中药有效成分,导入Cytoscape软件构建中药相关网络图,并预测关键作用靶点.结果 共获得 1880 个DEGs,其中表达上调的基因有1061个,表达下调的基因有819个.利用STRING数据库以及Cytoscape环境下的cytoHubba插件分析DEGs,筛选Dgree值排名 15 位的基因作为关键基因,分别是RPS27A、CDC42、EIF4E、MAPK1、PIK3R1、RPS6、RPS9、RPS8、RPL15、RPL27A、RPL24、RPL27、RPL26、RPL12 和 MAPK14.GO、KEGG 分析显示 DEGs主要参与配子生成、糖尿病并发症中的AGE-RAGE信号通路等信号通路.结论 筛选得到干预INCPH的潜在中药为人参、丹参、黄芪等,可能成为INCPH治疗的潜在分子药物来源.

Objective To with analyzing the gene expression profile of idiopathic non-cirrhotic portal hypertension(INCPH)by bioinformatics methods,we may obtain its key genes and signaling pathways to explore the molecular mechanism of INCPH and predict the potential traditional Chinese medicine.Methods The gene microarray dataset GSE77627 on INCPH was downloaded from gene expression omnibus(GEO)database,the data were normalized and screened for differential genes(DEGs)of INCPH using R language,and all DEGs were analyzed for gene ontology(GO)and Kyoto encyclopedia of genes and genomes(KEGG)enrichment using Metascape database,and protein-protein interaction network was constructed by STRING database;meanwhile DEGs with the top 15 Degree values were screened as key genes using CytoHubba plugin.Subsequently,the key genes were mapped to each other with the medical ontology information retrieval platform(coremine medical)to screen potential Chinese herbal medicines for the treatment of INCPH with P<0.05,and the potent components that potential Chinese medicines have were screened from the TCMSP database,imported into Cytoscape software to construct a Chinese medicine correlation network map and predict the key targets.Results A total of 1880 DEGs were screened,including 1061 up-regulated and 819 down-regulated genes.DEGs were analyzed using the protein interaction database STRING and cytoHubba in Cytoscape software to obtain key genes,which were RPS27A,CDC42,EIF4E,MAPK1,PIK3R1,RPS6,RPS9,RPS8,RPL15,RPL27A,RPL24,RPL27,RPL26,RPL12 and MAPK14.The GO and KEGG analysis mainly involved gamete production and AGE-RAGE signaling pathway in INCPH.Conclusion The potential traditional Chinese medicines screened for INCPH are Ginseng Radix et Rhizoma,Salviae Miltiorrhizae Radix et Rhizoma,Scutellariae Radix,etc,which may be a potential source of molecular drugs for the treatment of INCPH.

刘玥佩;钟颖;张萍;杨冉潋;李雷益

成都中医药大学临床医学院,四川成都 610072

基础医学

特发性非肝硬化性门静脉高压症;生物信息学;中药预测

Idiopathic non-cirrhotic portal hypertension;Bioinformatics(INCPH);Prediction of traditional Chinese medicine

《中国现代医生》 2024 (002)

49-53,61 / 6

10.3969/j.issn.1673-9701.2024.02.012

评论

下载量:0
点击量:0